Treatments

2026 is upon us!  As fireworks ring out around the world to usher in the new year, we like to look ahead and think about what new developments we might see in multiple sclerosis research over the coming 12...

Research Summary: Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease Researchers are constantly looking at novel approaches for the treatment of...

Research Summary: Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway Although not a new treatment approach, haematopoietic stem cell...

Research Summary: The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis One of the major developments in the treatment of multiple sclerosis has been the...

Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal...

What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B cells.  B cells, which are important cells in the immune system,...

Research Summary: Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study The treatment of progressive multiple sclerosis remains an unmet need. ...

Research Summary: Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis The ability to repair myelin damage...

Research Update: ATA188 Phase 2 EMBOLD Study Today, Atara Biotherapeutics provided an update on their Phase 2 randomised clinical trial, called the EMBOLD study, which is testing the safety and effectiveness...

Written by Brett Drummond (MStranslate co-founder), in collaboration with Joey Lambert (MStranslate intern) Autologous haematopoietic stem cell transplantation (AHSCT) is an exciting, recently developed...